Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. (Q45307012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

12

Steven M Hersch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

14

Robert J Ferrante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

13

M Flint Beal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Edward C Stack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Karen M Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kerry Cormier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

James K Kubilus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mikhail Bogdanov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Wayne R Matson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Lichuan Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bruce G Jenkins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Neil W Kowall

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ruth Luthi-Carter

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

12908-12915

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

27 December 2019

cites work

1 reference

12 December 2020

Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation.

1 reference

12 December 2020

A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods

1 reference

12 December 2020

Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures

1 reference

12 December 2020

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

1 reference

12 December 2020

Neuronal cell death in Huntington's disease: a potential role for dopamine

1 reference

12 December 2020

Mutant huntingtin enhances excitotoxic cell death.

1 reference

12 December 2020

Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.

1 reference

12 December 2020

Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.

1 reference

12 December 2020

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

1 reference

12 December 2020

Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.

1 reference

12 December 2020

Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.

1 reference

12 December 2020

Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene

1 reference

12 December 2020

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice

1 reference

12 December 2020

NMDA receptor function in mouse models of Huntington disease

1 reference

12 December 2020

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease

1 reference

12 December 2020

Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.

1 reference

12 December 2020

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

1 reference

12 December 2020

Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease

1 reference

12 December 2020

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease

1 reference

12 December 2020

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

1 reference

12 December 2020

Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage.

1 reference

12 December 2020

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

1 reference

12 December 2020

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

1 reference

12 December 2020

Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice

1 reference

12 December 2020

Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat.

1 reference

12 December 2020

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

1 reference

12 December 2020

Transcriptional abnormalities in Huntington disease

1 reference

12 December 2020

Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders

1 reference

12 December 2020

Alternative excitotoxic hypotheses

1 reference

12 December 2020

The toxic effect of sodium L-glutamate on the inner layers of the retina.

1 reference

12 December 2020

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

12 December 2020

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

1 reference

12 December 2020

Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract

1 reference

12 December 2020

Translating therapies for Huntington's disease from genetic animal models to clinical trials

1 reference

12 December 2020

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

1 reference

12 December 2020

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

1 reference

12 December 2020

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice

1 reference

12 December 2020

Association between BDNF Val66Met polymorphism and age at onset in Huntington disease.

1 reference

12 December 2020

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice

1 reference

12 December 2020

Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease

1 reference

12 December 2020

Oxidative damage in Huntington's disease pathogenesis

1 reference

12 December 2020

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease

1 reference

12 December 2020

Role of brain-derived neurotrophic factor in Huntington's disease

1 reference

12 December 2020

Modulation of nucleosome dynamics in Huntington's disease

1 reference

12 December 2020

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease

1 reference

12 December 2020

Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid.

1 reference

12 December 2020

Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain

1 reference

12 December 2020

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

12 December 2020

Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres

1 reference

12 December 2020

Selective sparing of a class of striatal neurons in Huntington's disease

1 reference

12 December 2020

Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease

1 reference

12 December 2020

Synaptic connections of callosal projection neurons in the vibrissal region of mouse primary motor cortex: an electron microscopic/horseradish peroxidase study

1 reference

12 December 2020

Spatial localization in NMR spectroscopy in vivo

1 reference

12 December 2020

Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum

1 reference

12 December 2020

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

12 December 2020

Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I.

1 reference

12 December 2020

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

1 reference

12 December 2020

Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization

1 reference

12 December 2020

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

12 December 2020

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

1 reference

12 December 2020

Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay.

1 reference

12 December 2020

Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport.

1 reference

12 December 2020

Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system.

1 reference

12 December 2020

Anterograde transport of brain-derived neurotrophic factor and its role in the brain.

1 reference

12 December 2020

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

1 reference

12 December 2020

Anterograde transport of neurotrophin proteins in the CNS--a reassessment of the neurotrophic hypothesis

1 reference

12 December 2020

Mitochondrial dysfunction in neurodegenerative diseases

1 reference

12 December 2020

Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

1 reference

12 December 2020

6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.

1 reference

12 December 2020

10.1523/JNEUROSCI.4318-07.2007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18032664%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference